Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study

OBJECTIVES: Iguratimod, a novel immunomodulatory agent for rheumatoid arthritis, has been shown to be effective against murine lupus. The aim of this study was to make a preliminary evaluation of the efficacy and safety of iguratimod as salvage therapy in patients with refractory lupus nephritis (LN...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yuening, Yan, Qingran, Fu, Qiong, Wang, Ran, Dai, Min, Du, Fang, Dai, Qing, Ye, Ping, Wu, Chunmei, Lu, Liangjing, Bao, Chunde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106733/
https://www.ncbi.nlm.nih.gov/pubmed/32228698
http://dx.doi.org/10.1186/s13075-020-02154-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106733/
https://www.ncbi.nlm.nih.gov/pubmed/32228698
http://dx.doi.org/10.1186/s13075-020-02154-7

Ejemplares similares